Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

Essai clinique

Effects of Anodal Transcranial Direct Current Stimulation on Muscle Inhibition After ACL Reconstruction

NCT : NCT07866963 · NOT_YET_RECRUITING

ID NCTNCT07866963
StatutNOT_YET_RECRUITING
SponsorUniversity of Lahore (OTHER)
First posted
Last updated

Résumé succinct

This randomized controlled trial will investigate the effects of anodal transcranial direct current stimulation (tDCS) on arthrogenic muscle inhibition in athletes following anterior cruciate ligament (ACL) reconstruction. Participants will be allocated into two groups: a control group receiving standard physical therapy and an experimental group receiving standard physical therapy combined with anodal tDCS over the primary motor cortex (M1). The tDCS intervention will be delivered at 2 mA for 20 minutes, three times per week for four weeks, immediately before supervised physiotherapy. The study will assess quadriceps muscle strength, arthrogenic muscle inhibition, neuromuscular control, and subjective knee function at baseline, four weeks, and eight weeks. The study aims to determine whether adding anodal tDCS to standard rehabilitation improves outcomes following ACL reconstruction.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.

↑